The Latin America, Middle East and Africa Pediatric Perfusion Market would witness market growth of 8.0% CAGR during the forecast period (2023-2030).
Pediatric perfusion represents a critical aspect of cardiac surgery for children facing congenital heart defects, acquired heart diseases, and other complex cardiac issues. This field plays a pivotal role in the use of cardiopulmonary bypass (CPB) machines and other perfusion technologies that provide circulatory and respiratory support during pediatric cardiac surgeries. It is a discipline that calls for a profound understanding of pediatric cardiovascular physiology, as well as a specialized approach to managing the unique challenges associated with young patients.
In pediatric cardiac surgery, the role of perfusionists is paramount. They ensure that oxygenated blood continues to circulate through the child's body while the heart is temporarily stopped during surgery, thereby sustaining life throughout the procedure. The success of these surgeries hinges on the proficiency of perfusionists and the quality of the equipment they employ. A number of factors have come together to drive a significant transformation in the field of pediatric perfusion in recent years. These include technological advancements, enhancements in surgical techniques, an upsurge in multidisciplinary collaboration, and a deepened understanding of pediatric cardiovascular physiology.
Argentina, like many countries in the LAMEA region, is witnessing an uptick in the demand for pediatric perfusion services. The country has invested in improving healthcare infrastructure and facilities specializing in pediatric cardiac care. Government support has been pivotal in enhancing the quality of pediatric perfusion services. The Hospital de Pediatría "Prof. Dr. Juan P. Garrahan" in Buenos Aires, for instance, is a prominent institution dedicated to pediatric healthcare and cardiac surgeries, contributing to the growing demand for perfusion services. Therefore, the region presents lucrative growth prospects for the growth of the market.
The Brazil market dominated the LAMEA Pediatric Perfusion Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $12,469.5 Thousands by 2030. The Argentina market is experiencing a CAGR of 8.6% during (2023 - 2030). Additionally, The UAE market would exhibit a CAGR of 7.7% during (2023 - 2030).
Based on End-use, the market is segmented into Hospitals, Cardiac Centers, and Others. Based on Product, the market is segmented into Pediatric Oxygenators, Pediatric Cannulae, Pediatric Blood Pumps, Pediatric Arterial Filters, Monitoring Systems and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, LivaNova PLC, Terumo Corporation, BL Lifesciences (BL group of family companies), Cardinal Health, Inc., EUROSETS S.R.L. (GVM Care Research), Getinge AB, Koninklijke Philips N.V., Nonin Medical, Inc. and GE HealthCare Technologies, Inc.
Pediatric perfusion represents a critical aspect of cardiac surgery for children facing congenital heart defects, acquired heart diseases, and other complex cardiac issues. This field plays a pivotal role in the use of cardiopulmonary bypass (CPB) machines and other perfusion technologies that provide circulatory and respiratory support during pediatric cardiac surgeries. It is a discipline that calls for a profound understanding of pediatric cardiovascular physiology, as well as a specialized approach to managing the unique challenges associated with young patients.
In pediatric cardiac surgery, the role of perfusionists is paramount. They ensure that oxygenated blood continues to circulate through the child's body while the heart is temporarily stopped during surgery, thereby sustaining life throughout the procedure. The success of these surgeries hinges on the proficiency of perfusionists and the quality of the equipment they employ. A number of factors have come together to drive a significant transformation in the field of pediatric perfusion in recent years. These include technological advancements, enhancements in surgical techniques, an upsurge in multidisciplinary collaboration, and a deepened understanding of pediatric cardiovascular physiology.
Argentina, like many countries in the LAMEA region, is witnessing an uptick in the demand for pediatric perfusion services. The country has invested in improving healthcare infrastructure and facilities specializing in pediatric cardiac care. Government support has been pivotal in enhancing the quality of pediatric perfusion services. The Hospital de Pediatría "Prof. Dr. Juan P. Garrahan" in Buenos Aires, for instance, is a prominent institution dedicated to pediatric healthcare and cardiac surgeries, contributing to the growing demand for perfusion services. Therefore, the region presents lucrative growth prospects for the growth of the market.
The Brazil market dominated the LAMEA Pediatric Perfusion Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $12,469.5 Thousands by 2030. The Argentina market is experiencing a CAGR of 8.6% during (2023 - 2030). Additionally, The UAE market would exhibit a CAGR of 7.7% during (2023 - 2030).
Based on End-use, the market is segmented into Hospitals, Cardiac Centers, and Others. Based on Product, the market is segmented into Pediatric Oxygenators, Pediatric Cannulae, Pediatric Blood Pumps, Pediatric Arterial Filters, Monitoring Systems and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, LivaNova PLC, Terumo Corporation, BL Lifesciences (BL group of family companies), Cardinal Health, Inc., EUROSETS S.R.L. (GVM Care Research), Getinge AB, Koninklijke Philips N.V., Nonin Medical, Inc. and GE HealthCare Technologies, Inc.
Scope of the Study
Market Segments Covered in the Report:
By End Use- Hospitals
- Cardiac Centers
- Others
- Pediatric Oxygenators
- Pediatric Cannulae
- Pediatric Blood Pumps
- Pediatric Arterial Filters
- Monitoring Systems
- Others
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Medtronic PLC
- LivaNova PLC
- Terumo Corporation
- BL Lifesciences (BL group of family companies)
- Cardinal Health, Inc.
- EUROSETS S.R.L. (GVM Care Research)
- Getinge AB
- Koninklijke Philips N.V.
- Nonin Medical, Inc.
- GE HealthCare Technologies, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 5. LAMEA Pediatric Perfusion Market by End-use
Chapter 6. LAMEA Pediatric Perfusion Market by Product
Chapter 7. LAMEA Pediatric Perfusion Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Medtronic PLC
- LivaNova PLC
- Terumo Corporation
- BL Lifesciences (BL group of family companies)
- Cardinal Health, Inc.
- EUROSETS S.R.L. (GVM Care Research)
- Getinge AB
- Koninklijke Philips N.V.
- Nonin Medical, Inc.
- GE HealthCare Technologies, Inc.
Methodology
LOADING...
